$10.6 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$14.86 - $34.80The lowest and highst price in the last 52 weeks.
-10.42xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$10.6 Billion|
|Enterprise Value||$33.7 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||+55.4%|
|Outstanding Shares||358 Million|
|Avg 30 Day Volume||1.48 Million|
|Earnings per Share||-$2.86|
|Price to Sales Ratio||1.35|
|Price to Book Ratio||-29.65|
|Revenue to Enterprise Value||4.19|
|EBIT to Enterprise Value||24.22|
|Total Debt to Enterprise Value||0.71|
|Debt to Equity||-120.5|
|Gross Profit||$5.74 Billion|
|Net Income||-$1.02 Billion|
|Quarterly Earnings Growth (YoY)||+301.3%|
|Return on Equity||516.75%|
|Return on Assets||-3.37%|
|Return on Invested Capital||5.49%|
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.
No summary available.Seeking Alpha, 1 day ago
No summary available.AB Newswire, 5 days ago
Scholarships Awarded to Nine Students Affected by Dermatologic Conditions LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ort...PR Newswire, 6 days ago